New 2-in-1 powder aerosol to upgrade fight against deadly superbugs in lungs
Purdue researchers have invented a dry powder inhaler drug formulation. It uses two synergistic antibiotics in one single particle that is shown to reach the infection sites in the deep lung area with the capability to kill multi-drug-resistant superbugs.